On March 18, Medicilon and Korea Pharmaceutical Manufacturers Association (KPMA) held a CFDA IND seminar in Seoul, South Korea. The theme of this seminar is “Experience Sharing and Exchange on CFDA’s IND Application and Drug Development Collaboration”. About 130 medical experts and scientists from more than 50 companies participated in this seminar. Medicilon CEO Dr. Chunlin Chen shared his CFDA IND application experience with Korean customers. Dr. Chen clearly explained the IND application process in China. The experts from South Korea showed strong interest in Medicilon’s IND service and further discussed the possibility of cooperation with Medicilon.